These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10689413)

  • 21. Treatment of viral hepatitis in children.
    Heller S; Valencia-Mayoral P
    Arch Med Res; 2007 Aug; 38(6):702-10. PubMed ID: 17613361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant alpha-2b-interferon in combination with antioxidants in the form of rectal suppositories (viferon) in children with chronic hepatitides B and C.
    Uchaikin V; Cherednichenko T; Malinovskaya V; Orlova T; Kovalev O; Kharlamova F; Chaplygina G; Konev V; Voronina F; Delenian N
    Acta Virol; 2000 Apr; 44(2):79-83. PubMed ID: 10989698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic viral hepatitis.
    Wright M; Main J; Thomas HC
    Antivir Chem Chemother; 2001 Jul; 12(4):201-12. PubMed ID: 11771729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of chronic hepatitis B and C virus infections.
    Chongsrisawat V; Poovorawan Y
    Indian J Pediatr; 2002 Feb; 69(2):149-54. PubMed ID: 11929032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)].
    Goriacheva LG; Romantsov MG; Agaeva SG; Lin'kov IuN; Kovalenko AL
    Antibiot Khimioter; 2010; 55(5-6):50-7. PubMed ID: 21033475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New interferon alfa formulation licensed for treatment of hepatitis C.
    Thompson CA
    Am J Health Syst Pharm; 2001 Mar; 58(6):452. PubMed ID: 11286138
    [No Abstract]   [Full Text] [Related]  

  • 27. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection.
    Seçkin D; Durusoy C; Sahin S
    Pediatr Dermatol; 2004; 21(5):577-9. PubMed ID: 15461767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABC of diseases of liver, pancreas, and biliary system: Chronic viral hepatitis.
    Ryder SD; Beckingham IJ
    BMJ; 2001 Jan; 322(7280):219-21. PubMed ID: 11159624
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in the management of viral hepatitis.
    Holt A
    J R Coll Physicians Edinb; 2011 Mar; 41(1):59-66. PubMed ID: 21365069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic HCV infection: public health threat and emerging consensus. Vienna, Austria, October 27-28, 1995.
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):1S-135S. PubMed ID: 9011465
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon alfa for chronic hepatitis C infection.
    Delgado Fernández M; Zambrana García JL; Díez García F
    Lancet; 1999 Feb; 353(9151):499-500. PubMed ID: 9989747
    [No Abstract]   [Full Text] [Related]  

  • 32. [Complex therapy of chronic viral hepatitis, occurring in combination with opisthorchosis].
    Chuĭkova KI
    Ter Arkh; 2002; 74(11):10-2. PubMed ID: 12498115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Consensus interferon: a new weapon in the treatment of chronic hepatitis C].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(3):211-2. PubMed ID: 10958058
    [No Abstract]   [Full Text] [Related]  

  • 34. Current concepts in viral hepatitis.
    Hoare JM; Forton DM
    J R Coll Physicians Lond; 2000; 34(5):481-4. PubMed ID: 11077665
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of patients with chronic viral hepatitis type B and C].
    Magiera M; Kucharz EJ; Beniowski M; Chełmicka A; Witor A; Witor A; Janczewska-Kazek E
    Pol Arch Med Wewn; 2003 Apr; 109(4):423-9. PubMed ID: 12931496
    [No Abstract]   [Full Text] [Related]  

  • 36. [AIDS research makes it possible--chronic hepatitis becomes curable].
    Gross H
    Dtsch Med Wochenschr; 2002 Aug; 127(33):1676. PubMed ID: 12243124
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: cure of chronic hepatitis B and D after 12 years of treatment with low-dose standard interferon alfa-2b.
    Burnevich E; Moiseev S; Mukhin N
    Aliment Pharmacol Ther; 2016 Sep; 44(6):649-50. PubMed ID: 27511138
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy, limitations, and outcomes of our current interferon-based therapies for hepatitis C.
    Kwo PY; Sozio MS
    Gastroenterology; 2013 Dec; 145(6):1488-90. PubMed ID: 24409497
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents?
    Gordon SC
    Postgrad Med; 2000 Feb; 107(2):135-8, 141-4. PubMed ID: 10689413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
    Yalcin K; Degertekin H; Yildiz F; Kilinc N
    J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.